HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
53 hedge funds and large institutions have $40.1M invested in HOOKIPA Pharma in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 7 closing their positions.
145% more capital invested
Capital invested by funds: $16.4M → $40.1M (+$23.7M)
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
18% more funds holding
Funds holding: 45 → 53 (+8)
1.81% more ownership
Funds ownership: 4.25% → 6.05% (+1.8%)
70% less call options, than puts
Call options by funds: $12K | Put options by funds: $40K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$5.79M |
| 2 |
AC
Armistice Capital
New York
|
+$4.28M |
| 3 |
AG
Artal Group
Luxembourg
|
+$4.24M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$3.31M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JFG
Jefferies Financial Group
New York
|
-$747K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$470K |
| 3 |
Millennium Management
New York
|
-$317K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$282K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$100K |
HOOK Hedge Fund Activity: Q2 2023 in Review
53 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q2 2023, worth a combined $40.1M — up 145% from $16.4M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new HOOK positions and 7 closed out — a net gain of 8 holders — while 14 added to existing stakes and 9 trimmed.
The largest buyer was Knoll Capital Management, adding an estimated $5.79M. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $747K sold.
- 53 institutional investors held HOOKIPA Pharma (HOOK) as of Q2 2023, up from 45 in Q1 2023.
- Funds reported $40.1M of HOOKIPA Pharma stock for Q2 2023, up 145% quarter-over-quarter.
- 15 funds opened new HOOKIPA Pharma positions in Q2 2023 and 7 closed out, a net change of +8 holders.
- The largest HOOKIPA Pharma buyer in Q2 2023 was Knoll Capital Management, an estimated $5.79M added.
- The largest HOOKIPA Pharma seller in Q2 2023 was Jefferies Financial Group, an estimated $747K sold.
Based on aggregated 13F filings for Q2 2023.